Novel dengue virus inhibitor 4-HPR activates ATF4 independent of protein kinase R–like Endoplasmic Reticulum Kinase and elevates levels of eIF2α phosphorylation in virus infected cells
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 130, 1-6
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (606409 and APP1059137)
- Senior Principal Research Fellowship (APP1002486/APP1103050)
This publication has 30 references indexed in Scilit:
- Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2α phosphorylationVirology Journal, 2013
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virusBiochemical Journal, 2012
- Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology GroupClinical Cancer Research, 2011
- Identification of Dihydroceramide Desaturase as a Direct in Vitro Target for FenretinideJournal of Biological Chemistry, 2011
- Dengue Virus Modulates the Unfolded Protein Response in a Time-dependent MannerJournal of Biological Chemistry, 2011
- West Nile Virus Differentially Modulates the Unfolded Protein Response To Facilitate Replication and Immune EvasionJournal of Virology, 2011
- CRM1-mediated Nuclear Export of Dengue Virus RNA Polymerase NS5 Modulates Interleukin-8 Induction and Virus ProductionJournal of Biological Chemistry, 2009
- On a mouse monoclonal antibody that neutralizes all four dengue virus serotypesJournal of General Virology, 2009
- Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancerAnnals of Oncology, 2006
- Diabetes Mellitus and Exocrine Pancreatic Dysfunction in Perk−/− Mice Reveals a Role for Translational Control in Secretory Cell SurvivalMolecular Cell, 2001